Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA.
Jens KlotscheKirsten MindenMartina NiewerthGerd HorneffPublished in: Annals of the rheumatic diseases (2018)
Patients who spent at least 12 months in inactive disease before MTX discontinuation had a significantly lower flare rate.